{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:21:16Z","timestamp":1793823676805,"version":"4.6.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s11864-023-01078-z","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T08:02:49Z","timestamp":1683273769000},"page":"880-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Recognition and Management of the Long-term Effects of Cranial Radiation"],"prefix":"10.1007","volume":"24","author":[{"given":"Sherif G.","family":"Shaaban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"LeCompte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence R.","family":"Kleinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin J.","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-8141","authenticated-orcid":false,"given":"Brandi R.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"issue":"3","key":"1078_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"\u2022\u2022 Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2021;18(3):170\u201386. This article is of major importance because due to the publication results of long-term clinical trial outcomes, and new diagnositic and prognostic algorithms, there was a need for new guidelines.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"1078_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/MED.0b013e3283631820","volume":"20","author":"KH Darzy","year":"2013","unstructured":"Darzy KH. Radiation-induced hypopituitarism. Curr Opin Endocrinol Diabetes Obes. 2013;20(4):342\u201353.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"1078_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1667\/RR1688.1","volume":"172","author":"EA Ainsbury","year":"2009","unstructured":"Ainsbury EA, Bouffler SD, D\u00f6rr W, Graw J, Muirhead CR, Edwards AA, et al. Radiation cataractogenesis: a review of recent studies. Radiat Res. 2009;172(1):1\u20139.","journal-title":"Radiat Res"},{"issue":"1","key":"1078_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<115::AID-CNCR17>3.0.CO;2-7","volume":"79","author":"FG Barker 2nd","year":"1997","unstructured":"Barker FG 2nd, Chang SM, Valk PE, Pounds TR, Prados MD. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer. 1997;79(1):115\u201326.","journal-title":"Cancer"},{"issue":"9","key":"1078_CR5","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/hed.24267","volume":"38","author":"EM Lambert","year":"2016","unstructured":"Lambert EM, Gunn GB, Gidley PW. Effects of radiation on the temporal bone in patients with head and neck cancer. Head Neck. 2016;38(9):1428\u201335.","journal-title":"Head Neck."},{"issue":"1","key":"1078_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.radonc.2016.02.016","volume":"119","author":"JM Borras","year":"2016","unstructured":"Borras JM, Lievens Y, Barton M, Corral J, Ferlay J, Bray F, et al. How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis. Radiother Oncol. 2016;119(1):5\u201311.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1078_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nrneurol.2016.185","volume":"13","author":"MT Makale","year":"2017","unstructured":"\u2022 Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol. 2017;13(1):52\u201364. This article describes mechanisms of brain injury.","journal-title":"Nat Rev Neurol"},{"key":"1078_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fonc.2012.00073","volume":"2","author":"D Greene-Schloesser","year":"2012","unstructured":"Greene-Schloesser D, Robbins ME, Peiffer AM, Shaw EG, Wheeler KT, Chan MD. Radiation-induced brain injury: a review. Front Oncol. 2012;2:73.","journal-title":"Front Oncol"},{"issue":"1","key":"1078_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1200\/JCO.2004.05.128","volume":"22","author":"CA Meyers","year":"2004","unstructured":"Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004;22(1):157\u201365.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1078_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11060-017-2375-2","volume":"134","author":"BM Ellingson","year":"2017","unstructured":"Ellingson BM, Chung C, Pope WB, Boxerman JL, Kaufmann TJ. Pseudoprogression, radionecrosis, inflammation or true tumor progression? Challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol. 2017;134(3):495\u2013504.","journal-title":"J Neurooncol"},{"issue":"1","key":"1078_CR11","doi-asserted-by":"publisher","first-page":"10176","DOI":"10.1038\/s41598-021-89216-1","volume":"11","author":"R Terziev","year":"2021","unstructured":"Terziev R, Psimaras D, Marie Y, Feuvret L, Berzero G, Jacob J, et al. Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors. Sci Rep. 2021;11(1):10176.","journal-title":"Sci Rep"},{"issue":"4","key":"1078_CR12","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/1097-0142(197910)44:4<1256::AID-CNCR2820440415>3.0.CO;2-T","volume":"44","author":"PC Burger","year":"1979","unstructured":"Burger PC, Mahley MS Jr, Dudka L, Vogel FS. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer. 1979;44(4):1256\u201372.","journal-title":"Cancer"},{"key":"1078_CR13","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Winter SF, Vaios EJ, Muzikansky A, Martinez-Lage M, Bussi\u00e8re MR, Shih HA, et al. Defining treatment-related adverse effects in patients with glioma: distinctive features of pseudoprogression and treatment-induced necrosis. Oncologist. 2020;25(8):e1221\u201332.\u00a0This paper describes methods in defining radiation necrosis in radiologic studies.","DOI":"10.1634\/theoncologist.2020-0085"},{"issue":"9","key":"1078_CR14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00066-013-0408-0","volume":"189","author":"V Strenger","year":"2013","unstructured":"Strenger V, Lackner H, Mayer R, Sminia P, Sovinz P, Mokry M, et al. Incidence and clinical course of radionecrosis in children with brain tumors. A 20-year longitudinal observational study. Strahlenther Onkol. 2013;189(9):759\u201364.","journal-title":"Strahlenther Onkol."},{"issue":"10","key":"1078_CR15","doi-asserted-by":"publisher","first-page":"e1392","DOI":"10.1212\/WNL.0000000000010190","volume":"95","author":"X Huang","year":"2020","unstructured":"Huang X, Zhang X, Wang X, Rong X, Li Y, Li H, et al. A nomogram to predict symptomatic epilepsy in patients with radiation-induced brain necrosis. Neurology. 2020;95(10):e1392\u2013403.","journal-title":"Neurology"},{"issue":"9","key":"1078_CR16","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/neuonc\/noz048","volume":"21","author":"SF Winter","year":"2019","unstructured":"Winter SF, Loebel F, Loeffler J, Batchelor TT, Martinez-Lage M, Vajkoczy P, et al. Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncology. Neuro Oncol. 2019;21(9):1118\u201330.","journal-title":"Neuro Oncol"},{"issue":"6","key":"1078_CR17","first-page":"1455","volume":"26","author":"C Asao","year":"2005","unstructured":"Asao C, Korogi Y, Kitajima M, Hirai T, Baba Y, Makino K, et al. Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol. 2005;26(6):1455\u201360.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"1078_CR18","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1227\/01.NEU.0000119328.56431.A7","volume":"54","author":"JP Rock","year":"2004","unstructured":"Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rosenblum M, et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery. 2004;54(5):1111\u20137 (discussion 7-9).","journal-title":"Neurosurgery."},{"issue":"5","key":"1078_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3171\/jns.2004.100.5.0835","volume":"100","author":"T Kimura","year":"2004","unstructured":"Kimura T, Sako K, Tanaka K, Gotoh T, Yoshida H, Aburano T, et al. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging. J Neurosurg. 2004;100(5):835\u201341.","journal-title":"J Neurosurg"},{"issue":"1","key":"1078_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3171\/jns.1998.89.1.0060","volume":"89","author":"RB Schwartz","year":"1998","unstructured":"Schwartz RB, Holman BL, Polak JF, Garada BM, Schwartz MS, Folkerth R, et al. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg. 1998;89(1):60\u20138.","journal-title":"J Neurosurg"},{"issue":"1","key":"1078_CR21","first-page":"vdab150","volume":"3","author":"X Chen","year":"2021","unstructured":"\u2022\u2022 Chen X, Parekh VS, Peng L, Chan MD, Redmond KJ, Soike M, et al. Multiparametric radiomic tissue signature and machine learning for distinguishing radiation necrosis from tumor progression after stereotactic radiosurgery. Neurooncol Adv. 2021;3(1):vdab150. This article is of major recent importance as it describes a new technique (MRI-based multiparametric radiomics) to help distinguish between radiation necrosis and tumor progression.","journal-title":"Neurooncol Adv."},{"issue":"6","key":"1078_CR22","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1227\/NEU.0b013e3181fa775b","volume":"67","author":"C Kotsarini","year":"2010","unstructured":"Kotsarini C, Griffiths PD, Wilkinson ID, Hoggard N. A systematic review of the literature on the effects of dexamethasone on the brain from in vivo human-based studies: implications for physiological brain imaging of patients with intracranial tumors. Neurosurgery. 2010;67(6):1799\u2013815 (discussion 815).","journal-title":"Neurosurgery."},{"issue":"1","key":"1078_CR23","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3892\/ol.2017.6251","volume":"14","author":"KJ Wenger","year":"2017","unstructured":"Wenger KJ, Wagner M, You SJ, Franz K, Harter PN, Burger MC, et al. Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine. Oncol Lett. 2017;14(1):1141\u20136.","journal-title":"Oncol Lett"},{"issue":"5","key":"1078_CR24","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","volume":"79","author":"VA Levin","year":"2011","unstructured":"Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011;79(5):1487\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1078_CR25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.ijrobp.2018.04.068","volume":"101","author":"Y Xu","year":"2018","unstructured":"Xu Y, Rong X, Hu W, Huang X, Li Y, Zheng D, et al. Bevacizumab monotherapy reduces radiation-induced brain necrosis in nasopharyngeal carcinoma patients: a randomized controlled trial. Int J Radiat Oncol Biol Phys. 2018;101(5):1087\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1078_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1023\/B:NEON.0000024744.16031.e9","volume":"68","author":"CM McPherson","year":"2004","unstructured":"McPherson CM, Warnick RE. Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol. 2004;68(1):41\u20137.","journal-title":"J Neurooncol"},{"issue":"3","key":"1078_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11060-021-03790-y","volume":"153","author":"WC Newman","year":"2021","unstructured":"\u2022\u2022 Newman WC, Goldberg J, Guadix SW, Brown S, Reiner AS, Panageas K, et al. The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes. J Neurooncol. 2021;153(3):507\u201318. This article of importance outlined the role for extent of resection for radiation necrosis and its role in improving decreased use of steroids.","journal-title":"J Neurooncol"},{"issue":"1","key":"1078_CR28","first-page":"50","volume":"117","author":"B Patel","year":"2020","unstructured":"Patel B, Kim AH. Laser Interstitial Thermal Therapy. Mo Med. 2020;117(1):50\u20135.","journal-title":"Mo Med"},{"issue":"10","key":"1078_CR29","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<2005::AID-CNCR19>3.0.CO;2-0","volume":"80","author":"PJ Chuba","year":"1997","unstructured":"Chuba PJ, Aronin P, Bhambhani K, Eichenhorn M, Zamarano L, Cianci P, et al. Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer. 1997;80(10):2005\u201312.","journal-title":"Cancer"},{"issue":"8","key":"1078_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/jso.21387","volume":"100","author":"YB Cihan","year":"2009","unstructured":"Cihan YB, Uzun G, Yildiz S, D\u00f6nmez H. Hyperbaric oxygen therapy for radiation-induced brain necrosis in a patient with primary central nervous system lymphoma. J Surg Oncol. 2009;100(8):732\u20135.","journal-title":"J Surg Oncol"},{"issue":"2","key":"1078_CR31","first-page":"357","volume":"21","author":"RG Henry","year":"2000","unstructured":"Henry RG, Vigneron DB, Fischbein NJ, Grant PE, Day MR, Noworolski SM, et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol. 2000;21(2):357\u201366.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"1078_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.expneurol.2004.05.005","volume":"188","author":"R Rola","year":"2004","unstructured":"Rola R, Raber J, Rizk A, Otsuka S, VandenBerg SR, Morhardt DR, et al. Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Exp Neurol. 2004;188(2):316\u201330.","journal-title":"Exp Neurol"},{"issue":"8","key":"1078_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1212\/WNL.0b013e318283bb0a","volume":"80","author":"AM Peiffer","year":"2013","unstructured":"Peiffer AM, Leyrer CM, Greene-Schloesser DM, Shing E, Kearns WT, Hinson WH, et al. Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology. 2013;80(8):747\u201353.","journal-title":"Neurology"},{"issue":"5","key":"1078_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11864-019-0641-6","volume":"20","author":"CK Cramer","year":"2019","unstructured":"\u2022\u2022 Cramer CK, Cummings TL, Andrews RN, Strowd R, Rapp SR, Shaw EG, et al. Treatment of radiation-induced cognitive decline in adult brain tumor patients. Curr Treat Options Oncol. 2019;20(5):42. This article of importance is a review of treatment options for radiation-induced cognitive decline.","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"1078_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2214\/ajr.149.1.165","volume":"149","author":"JS Tsuruda","year":"1987","unstructured":"Tsuruda JS, Kortman KE, Bradley WG, Wheeler DC, Van Dalsem W, Bradley TP. Radiation effects on cerebral white matter: MR evaluation. AJR Am J Roentgenol. 1987;149(1):165\u201371.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"1078_CR36","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.ijrobp.2011.01.068","volume":"82","author":"CH Chapman","year":"2012","unstructured":"Chapman CH, Nagesh V, Sundgren PC, Buchtel H, Chenevert TL, Junck L, et al. Diffusion tensor imaging of normal-appearing white matter as biomarker for radiation-induced late delayed cognitive decline. Int J Radiat Oncol Biol Phys. 2012;82(5):2033\u201340.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1078_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.radonc.2016.06.021","volume":"120","author":"CH Chapman","year":"2016","unstructured":"Chapman CH, Zhu T, Nazem-Zadeh M, Tao Y, Buchtel HA, Tsien CI, et al. Diffusion tensor imaging predicts cognitive function change following partial brain radiotherapy for low-grade and benign tumors. Radiother Oncol. 2016;120(2):234\u201340.","journal-title":"Radiother Oncol"},{"issue":"12","key":"1078_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11910-013-0415-7","volume":"13","author":"AM Brickman","year":"2013","unstructured":"Brickman AM. Contemplating Alzheimer\u2019s disease and the contribution of white matter hyperintensities. Curr Neurol Neurosci Rep. 2013;13(12):415.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"1078_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0167-8140(03)00192-0","volume":"69","author":"TB Johannesen","year":"2003","unstructured":"Johannesen TB, Lien HH, Hole KH, Lote K. Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy. Radiother Oncol. 2003;69(2):169\u201376.","journal-title":"Radiother Oncol"},{"key":"1078_CR40","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1200\/JCO.2003.07.080","volume":"21","author":"CA Meyers","year":"2003","unstructured":"Meyers CA, Wefel JS. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol. 2003;21:3557\u20138 (United States).","journal-title":"J Clin Oncol."},{"issue":"2","key":"1078_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","volume":"19","author":"TN Tombaugh","year":"2004","unstructured":"Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19(2):203\u201314.","journal-title":"Arch Clin Neuropsychol"},{"issue":"1\u20133","key":"1078_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF01345268","volume":"14","author":"W Danysz","year":"1998","unstructured":"Danysz W, Parsons CG, Karcz-Kubicha M, Schwaier A, Popik P, Wedzony K, et al. GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality. Amino Acids. 1998;14(1\u20133):235\u20139.","journal-title":"Amino Acids."},{"issue":"10","key":"1078_CR43","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/neuonc\/not114","volume":"15","author":"PD Brown","year":"2013","unstructured":"\u2022 Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol. 2013;15(10):1429\u201337. This sentinel paper describes a treatment option for preventing cognitive decline in patients receiving whole brain radiotherapy.","journal-title":"Neuro Oncol"},{"issue":"10","key":"1078_CR44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1200\/JCO.19.02767","volume":"38","author":"PD Brown","year":"2020","unstructured":"\u2022\u2022 Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, et al. Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001. J Clin Oncol. 2020;38(10):1019\u201329. This article of major importance describes the clinical trial showing benefit to cognition sparing using a technique of intensity-modulated radiotherapy for hippocampal-sparing.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1078_CR45","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1093\/neuros\/nyaa107","volume":"87","author":"C Gui","year":"2020","unstructured":"Gui C, Vannorsdall TD, Kleinberg LR, Assadi R, Moore JA, Hu C, et al. A prospective cohort study of neural progenitor cell-sparing radiation therapy plus temozolomide for newly diagnosed patients with glioblastoma. Neurosurgery. 2020;87(1):E31-e40.","journal-title":"Neurosurgery"},{"key":"1078_CR46","doi-asserted-by":"crossref","unstructured":"Gondi V, Pugh S, P DB, Wefel J, Gilbert M, Bovi J, et al. NCOG-01. Preservation of neurocognitive function (NCF) with hippocampal avoidance during whole-brain radiotherapy (WBRT) for brain metastases: preliminary results of phase III trial NRG oncology CC001. Neuro Oncol. 20: \u00a9 The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.; 2018. p. vi172.","DOI":"10.1093\/neuonc\/noy148.716"},{"issue":"4","key":"1078_CR47","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11864-014-0307-3","volume":"15","author":"A Attia","year":"2014","unstructured":"Attia A, Page BR, Lesser GJ, Chan M. Treatment of radiation-induced cognitive decline. Curr Treat Options Oncol. 2014;15(4):539\u201350.","journal-title":"Curr Treat Options Oncol"},{"issue":"15","key":"1078_CR48","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1200\/JCO.2014.58.4508","volume":"33","author":"SR Rapp","year":"2015","unstructured":"Rapp SR, Case LD, Peiffer A, Naughton MM, Chan MD, Stieber VW, et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. J Clin Oncol. 2015;33(15):1653\u20139.","journal-title":"J Clin Oncol"},{"issue":"23","key":"1078_CR49","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1200\/JCO.2004.04.128","volume":"22","author":"RK Mulhern","year":"2004","unstructured":"Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, Bonner M, et al. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol. 2004;22(23):4795\u2013803.","journal-title":"J Clin Oncol"},{"issue":"23","key":"1078_CR50","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1200\/JCO.2003.06.156","volume":"21","author":"E Bruera","year":"2003","unstructured":"Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL, et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol. 2003;21(23):4439\u201343.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1078_CR51","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.ijrobp.2007.05.076","volume":"69","author":"JM Butler Jr","year":"2007","unstructured":"Butler JM Jr, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007;69(5):1496\u2013501.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"1078_CR52","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/neuonc\/nov084","volume":"17","author":"BR Page","year":"2015","unstructured":"Page BR, Shaw EG, Lu L, Bryant D, Grisell D, Lesser GJ, et al. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro Oncol. 2015;17(10):1393\u2013401.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1078_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jamaoncol.2021.5948","volume":"8","author":"AB Porter","year":"2022","unstructured":"Porter AB, Liu H, Kohli S, Cerhan JL, Sloan J, McMurray RP, et al. Efficacy of treatment with armodafinil for cancer-related fatigue in patients with high-grade glioma: a phase 3 randomized clinical trial. JAMA Oncol. 2022;8(2):259\u201367.","journal-title":"JAMA Oncol"},{"issue":"3","key":"1078_CR54","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/cen.12969","volume":"84","author":"N Kyriakakis","year":"2016","unstructured":"Kyriakakis N, Lynch J, Orme SM, Gerrard G, Hatfield P, Loughrey C, et al. Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours. Clin Endocrinol (Oxf). 2016;84(3):372\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1078_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ncpendmet1051","volume":"5","author":"KH Darzy","year":"2009","unstructured":"Darzy KH. Radiation-induced hypopituitarism after cancer therapy: who, how and when to test. Nat Clin Pract Endocrinol Metab. 2009;5(2):88\u201399.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"287","key":"1078_CR56","first-page":"265","volume":"78","author":"MD Littley","year":"1991","unstructured":"Littley MD, Shalet SM, Morgenstern GR, Deakin DP. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Q J Med. 1991;78(287):265\u201374.","journal-title":"Q J Med"},{"issue":"8","key":"1078_CR57","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1210\/jc.2011-0306","volume":"96","author":"NM Appelman-Dijkstra","year":"2011","unstructured":"Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OM, Neelis KJ, Biermasz NR, Romijn JA, et al. Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(8):2330\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1078_CR58","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0360-3016(01)02757-2","volume":"52","author":"ML van Kempen-Harteveld","year":"2002","unstructured":"van Kempen-Harteveld ML, Struikmans H, Kal HB, van der Tweel I, Mourits MP, Verdonck LF, et al. Cataract after total body irradiation and bone marrow transplantation: degree of visual impairment. Int J Radiat Oncol Biol Phys. 2002;52(5):1375\u201380.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"1078_CR59","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","volume":"76","author":"C Mayo","year":"2010","unstructured":"Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S28-35.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1078_CR60","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.radonc.2019.02.003","volume":"134","author":"S Brecht","year":"2019","unstructured":"\u2022\u2022 Brecht S, Boda-Heggemann J, Budjan J, Siebenlist K, Stieler F, Steil V, et al. Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT). Radiother Oncol. 2019;134:166\u201377. This paper of importance examined patients receiving 50 Gy or more to the anterior visual pathway using modern radiation techniques, showing very low risk of radiation-induced optic neuropathy.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1078_CR61","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ijrobp.2006.09.017","volume":"67","author":"N Bhandare","year":"2007","unstructured":"Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys. 2007;67(2):469\u201379.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-023-01078-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-023-01078-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-023-01078-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T06:13:21Z","timestamp":1686809601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-023-01078-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1078"],"URL":"https:\/\/doi.org\/10.1007\/s11864-023-01078-z","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"assertion":[{"value":"8 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Sherif Shabaan declares no conflict of interest. Michael LeCompte declares no conflict of interest. Lawrence Kleinberg declares the following: research funding from Novartis, research funding from BMS, research funding from Incyte, research funding from Novocure, and reports service as a consultant to Novocure. Kristin Redmond declares the following: funding for research, travel, speaking honoraria from Elekta; funding for research, travel, and speaking honoraria from Accuray, research funding from Canon; travel expense funding from BrainLab; travel expense funding from Icotec; and reports service as a consultant\/data safety monitoring board member for BioMimetrix. Brandi Page declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}